IgTT 1E
Alternative Names: Bispecific IgTT 1E antibodies; IgTT-1ELatest Information Update: 30 Jun 2023
At a glance
- Originator LeadArtis
- Class Antibodies; Antineoplastics; Immunotherapies
- Mechanism of Action Antibody-dependent cell cytotoxicity; Immunologic cytotoxicity
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer